Covered recipient · General Payments record
DANIEL ROSENBAUM
Allopathic & Osteopathic Physicians Internal Medicine Endocrinology, Diabetes & Metabolism
General Payments · PY2018–2024
$6,654.06
- Reported across 256 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,585.95 | 65 |
| Long term medical supply or device loan | $49.95 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Abbott Laboratories | $482.61 | 7 |
| Novo Nordisk AS | $267.07 | 11 |
| Insulet Corporation | $90.79 | 4 |
| Lilly USA, LLC | $83.30 | 5 |
| Amgen Inc. | $76.01 | 5 |
| MannKind Corporation | $67.41 | 4 |
| Corcept Therapeutics | $62.29 | 3 |
| CeQur Corporation | $61.72 | 1 |
| SANOFI-AVENTIS U.S. LLC | $49.46 | 3 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $42.63 | 2 |
| Antares Pharma, Inc. | $38.20 | 2 |
| Janssen Biotech, Inc. | $32.87 | 2 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $32.03 | 2 |
| Xeris Pharmaceuticals, Inc. | $31.78 | 2 |
| Takeda Pharmaceuticals U.S.A., Inc. | $31.06 | 2 |
| Merck Sharp & Dohme Corporation | $30.91 | 2 |
| ABBVIE INC. | $29.41 | 2 |
| Verity Pharmaceuticals Inc. | $26.63 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $18.48 | 1 |
| Janssen Pharmaceuticals, Inc | $17.79 | 1 |
| Ardelyx, Inc. | $16.92 | 1 |
| IBSA Pharma Inc. | $16.86 | 1 |
| Rhythm Pharmaceuticals, Inc. | $15.38 | 1 |
| Ascendis Pharma Inc | $14.29 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (66)
Sorted by paying entity, then date · as published by CMS
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.